(Health-NewsWire.Net, May 03, 2017 ) Asia-Pacific Diabetic Retinopathy Market research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 7.94% to reach USD 2.15 billion by 2021, from USD 1.46 billion in 2016, which amounts to a cumulative growth of USD 0.69 billion.
Diabetic retinopathy is an ailment that arises in people suffering from diabetes. It leads to progressive damage to the light sensitive lining behind the eye, that’s retina. A serious complication of diabetes which is sight menacing is known as diabetic retinopathy.
Laser treatment is used to prevent fluids and blood from entering into the retina. To seal the leaks with abnormal blood vessel, a beam light is used for creation of small burns in those areas of retina. The treatment of diabetic retinopathy depends upon its stages. For treatment of initial stages of diabetic retinopathy, regular monitoring is essential but when the stage advances, laser treatment is necessary. The motive of any treatment is to prevent or slow the disease progression.
Get free Sample report at http://www.marketdataforecast.com/market-reports/asia-pacific-diabetic-retinopathy-market-939/request-sample
The report also presents detailed analysis of multitude of factors affecting the diagnostic imaging market bearing either positive or negative outcomes. Some of those factors are
• Increasing prevalence of diabetes • Improving healthcare infrastructure in developing markets • Focusing on increasing foothold of low income countries • Increasing diabetes awareness by government and non-government initiatives • Stringent Government Regulations • Lack of skilled professionals
For granular level understanding the Diabetic Retinopathy Market is segmented based on indication, treatment type and end users, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on indication the market is segmented into Non-Proliferative Diabetic Retinopathy (NPDR)( Mild, Moderate and Severe) and Proliferative Diabetic Retinopathy (PDR). Based on Treatment type the market is further segmented into Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy. Based on end users the market is furthermore segmented among Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers.
With India and China being the major economies which have unexplored customer base covered in the study the report also focuses on other regions like Japan, Australia, South Korea and Rest of Asia-Pacific. Along with India and China other low income countries of Asia-pacific are estimated to be the fastest growing markets due to their investment in healthcare infrastructural facilities.
Some of the key players that operate in the Diabetic Retinopathy market include Valeant Pharmaceutical International Inc., Abbott Laboratories Inc. and Alimera Science Inc. Internationally, North America and Europe constitutes up to 50% of the global diabetic retinopathy market.
The Asia- Pacific Diabetic Retinopathy market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of indication, treatment type and end users, along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Therapeutics Market:
• Colorectal Cancer diagnosis market:http://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/
• Clinical nutrition Market: http://www.marketdataforecast.com/market-reports/asia-pacific-clinical-nutrition-market-788/
• Autoimmune Monoclonal Market: http://www.marketdataforecast.com/market-reports/global-autoimmune-monoclonal-antibodies-1170/
• Burn care Market: http://www.marketdataforecast.com/market-reports/global-burn-care-market-1077/
• Cancer immunotherapy market:http://www.marketdataforecast.com/market-reports/global-cancer-immunotherapy-market-1412/
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|